Acalabrutinib and Pleural effusion - a phase IV clinical study of FDA data

Summary:

Pleural effusion is reported as a side effect among people who take Acalabrutinib (acalabrutinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Bendamustine Hydrochloride, and have Mantle cell lymphoma.

The phase IV clinical study analyzes which people have Pleural effusion when taking Acalabrutinib. It is created by eHealthMe based on reports of 1,237 people who have side effects when taking Acalabrutinib from the FDA, and is updated regularly.

What is Acalabrutinib?

Acalabrutinib has active ingredients of acalabrutinib. eHealthMe is studying from 1,237 Acalabrutinib users. Check the latest studies of Acalabrutinib.

What is Pleural effusion?

Pleural effusion (water on the lungs) is found to be associated with 2,221 drugs and 3,147 conditions by eHealthMe. Check the latest studies of Pleural effusion.

On Aug, 07, 2026

1,237 people reported to have side effects when taking Acalabrutinib.
Among them, 15 people (1.21%) have Pleural effusion.

Could Acalabrutinib cause Pleural effusion?

Among these 15 people:

How long have people been on Acalabrutinib when they have Pleural effusion? *

What is the gender of people who have Pleural effusion when taking Acalabrutinib? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Pleural effusion when taking Acalabrutinib? *

What are other drugs people take besides Acalabrutinib? *

Acyclovir: 3 people, 20.00%
Entecavir: 3 people, 20.00%
Bendamustine Hydrochloride: 3 people, 20.00%
Furosemide: 2 people, 13.33%
Atorvastatin Calcium: 2 people, 13.33%
Metoprolol Succinate: 2 people, 13.33%
Solu-Medrol: 2 people, 13.33%
Bendamustine: 2 people, 13.33%
Promethazine Hydrochloride: 2 people, 13.33%
Aspirin: 2 people, 13.33%

What are other side effects people have besides Pleural effusion? *

Cytomegalovirus Infection: 2 people, 13.33%
Thrombocytopenia (decrease of platelets in blood): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 13.33%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 13.33%
White Blood Cell Count Decreased: 1 person, 6.67%
Fatigue (feeling of tiredness): 1 person, 6.67%
Enlarged Prostate: 1 person, 6.67%
Dyspnea Exertional: 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%

What are the existing conditions these people have? *

Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 7 people, 46.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 33.33%
High Blood Pressure: 2 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
Allergies: 2 people, 13.33%
Thrombocytopenia (decrease of platelets in blood): 1 person, 6.67%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 1 person, 6.67%
Pain: 1 person, 6.67%
Nausea (feeling of having an urge to vomit): 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Acalabrutinib and have Pleural effusion?

- Check whether Pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acalabrutinib:

Acalabrutinib (1,237 reports)

Pleural effusion treatments and more:

Pleural effusion (84,634 reports)

Browse all side effects of Acalabrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleural effusion:

Pleural effusion (2,221 drugs)

Browse all the conditions that are associated with Pleural effusion:

Pleural effusion (3,147 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acalabrutinib (the active ingredients of Acalabrutinib) and Acalabrutinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.